CAERUS CAPITAL AS
Operating
Produktutvikling i farmasøytisk industri, konsulentvirksomhet,
investeringsvirksomhet samt deltakelse i andre foretak.
Utvikling og salg av produkter og tjenester rettet mot farmasøytiske
og medisinsktekniske selskaper.
Keywords
productionpharmaceuticalsantiserablood fractionsvaccineshomeopathic preparationscontraceptive productsbone buildingdiagnostic preparationspregnancy testsbiotechnological medicinescotton woolgasbandagesdressings
Organization
- CEO
- TV
Torgeir Vaage1964
- Chairman of the board
- TV
Torgeir Vaage1964
- Years since formation
- 24 years
- since Mar 9, 2002
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 1
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2024
- 1,589,969
- NOK
- Annual total result 2024
- 2,600,868
- NOK
- Total equity 2024
- 8,078,199
- NOK
Last update: Dec 12, 2025
Locations
- Company addressc/o Torgeir Vaage Gabels gate 43A 0262 OSLO, Norge
Copied!
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
TV 1964 | Managing Director/CEO | 100 % directly |
Board
| Name | Role | Shares |
|---|---|---|
TV 1964 | Chairman | 100 % directly |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
TV 1964 | Managing Director/CEO, Chairman | 100 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
TV 1964 | Ordinary shares | 1 | 100 % |
Shares owned by the CAERUS CAPITAL AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
P PROPHYLIX PHARMA HOLDING AS | H-shares | 6,000 | 0.99 % |
A ALGINOR ASA | NO0010756042 | 8,850 | 0.03 % |
P PROXIMAR SEAFOOD AS | NO0010893902 | 39,538 | 0.03 % |
P PARETO BANK ASA | NO0010397581 | 20,000 | 0.03 % |
E ELOPAK ASA | NO0011002586 | 1,607 | < 0.01 % |
V Veidekke ASA | NO0005806802 | 500 | < 0.01 % |
S STOREBRAND ASA | NO0003053605 | 3,500 | < 0.01 % |
A AXACTOR ASA | NO0010840515 | 10,000 | < 0.01 % |
D DNO ASA | NO0003921009 | 30,000 | < 0.01 % |
V VÅR ENERGI ASA | NO0011202772 | 16,000 | < 0.01 % |
A AKER HORIZONS ASA Under liquidation | NO0010921232 | 5,000 | < 0.01 % |
A AUSTEVOLL SEAFOOD ASA | NO0010073489 | 5,000 | < 0.01 % |
S SPAREBANK 1 SMN | NO0006390301 | 1,000 | < 0.01 % |
A ABG SUNDAL COLLIER HOLDING ASA | NO0003021909 | 35,000 | < 0.01 % |
K KONGSBERG AUTOMOTIVE ASA | NO0003033102 | 10,000 | < 0.01 % |
N NORDIC SEMICONDUCTOR ASA | NO0003055501 | 750 | < 0.01 % |
M MOWI ASA | NO0003054108 | 500 | < 0.01 % |
K KOMPLETT ASA | NO0011016040 | 850 | < 0.01 % |
T TELENOR ASA | NO0010063308 | 1,000 | < 0.01 % |
Y YARA INTERNATIONAL ASA | NO0010208051 | 1,150 | < 0.01 % |
A AKER BP ASA | NO0010345853 | 600 | < 0.01 % |
M MORROW BANK ASA Closed | NO0010694029 | 5,000 | < 0.01 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 1,589,969 | 1,237,928 | 0 | 0 |
Annual Total Result | 2,600,868 | 2,722,406 | -546,209 | 3,041,290 |
Total assets | 9,669,476 | 8,979,535 | 6,245,773 | 6,485,687 |
Total liabilities | 1,591,277 | 3,502,205 | 3,490,849 | 3,184,553 |
Total equity | 8,078,199 | 5,477,331 | 2,754,925 | 3,301,134 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 1,589,969 | 1,237,928 | 0 | 0 |
Total operating costs | 31,177 | 22,228 | 21,443 | 22,125 |
Operating result | 1,558,792 | 1,215,700 | -21,443 | -22,125 |
Financial income/costs | 1,042,076 | 1,506,706 | -524,766 | 3,063,415 |
Profit before tax | 2,600,868 | 2,722,406 | -546,209 | 3,041,290 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | 2,600,868 | 2,722,406 | -546,209 | 3,041,290 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 |
Total current assets | 9,669,476 | 8,979,535 | 6,245,773 | 6,485,687 |
Total assets | 9,669,476 | 8,979,535 | 6,245,773 | 6,485,687 |
Short term debt | 38,086 | 228,682 | 288,307 | 3,184,553 |
Long term debt | 1,553,191 | 3,273,523 | 3,202,542 | 0 |
Total liabilities | 1,591,277 | 3,502,205 | 3,490,849 | 3,184,553 |
Contributed capital | 3,438,652 | 3,438,652 | 3,438,652 | 3,438,652 |
Retained earnings | 4,639,547 | 2,038,679 | -683,727 | -137,519 |
Total equity | 8,078,199 | 5,477,331 | 2,754,925 | 3,301,134 |
Total equity and liabilities | 9,669,476 | 8,979,536 | 6,245,774 | 6,485,687 |
Classification
21st company classification
BETA
Small company
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
21
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2
Main industrial group
Manufacture of pharmaceutical preparations
21.20
Industrial group
Manufacture of pharmaceutical preparations
21.200
Industrial group
Manufacture of pharmaceutical preparations